Total Anti-Infliximab
Detecting the presence of total (free and bound) antibodies against Infliximab in patients being treated with Infliximab for chronic autoimmune and inflammatory conditions.
Therapeutic Drug Monitoring (TDM) is to optimize biologic treatment for an individual patient. AFIAS Total Anti-Infliximab can detect the presence of anti-drug antibodies against Infliximab, requiring only a small amount of human serum or plasma, and delivering results in 22 minutes. This allows physicians to verify the presence of anti-drug antibodies immediately before the next administration.
About Using Reagent
-
Sample Types
Serum, Plasma -
Reaction Time
22 mins -
Detection Range
8-250 AU/mL -
Intended Use
Semi-quantitative determination of free and bound antibodies against Infliximab in human serum/plasma
In Your Medical Field
AFIAS Total Anti-Infliximab test detects the total (free and bound) antibodies against Infliximab with a small amount of human serum or plasma. It provides valuable insights into patients’ response to the treatment of Infliximab.